Botswana To Purchase ViiV Healthcare HIV Medicine In Largest-Ever African Transaction

Financial Times: GSK’s HIV unit secures biggest ever tender in sub-Saharan Africa
“GlaxoSmithKline’s HIV drugs business, ViiV Healthcare, has secured its biggest ever tender in sub-Saharan Africa that will see its dolutegravir treatment made available to people living with the virus through a national health program for the first time…” (6/3).

Reuters: Botswana gets GSK’s modern HIV drug in largest-ever Africa tender
“…Campaign groups like Médecins Sans Frontières have been pushing for the new drug to be offered to people in developing countries since it was first approved in the United States in 2013, as the drug is well tolerated and extremely effective. No financial details were given of the contract between ViiV and the Ministry of Health in Botswana, and a GSK spokesman declined comment on price…” (Hirschler, 6/3).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.